Viromed Medical AG (FRA:VME) PE Ratio (TTM): 242.86 (As of Jul. 03, 2026) — 10% Above Median


FRA:VME Viromed Medical AG FRA:VME
22 GF Score
Price €6.80
! 5 Warning Signs
View Full Analysis

What is Viromed Medical AG PE Ratio (TTM)?

Viromed Medical AG FRA:VME +0.74% 22 PE Ratio (TTM) is 242.86 as of Jul. 03, 2026, which is 10% above its 10-year median of 221.43. GuruFocus rates FRA:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 435 Medical Devices & Instruments companies, Viromed Medical AG ranks worse than 96.55% on this metric.

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-03), Viromed Medical AG's share price is €6.80. Viromed Medical AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03. Therefore, Viromed Medical AG's PE Ratio (TTM) for today is 242.86.

Warning Sign:

Viromed Medical AG stock PE Ratio (=242.86) is close to 1-year high of 264.29.


The historical rank and industry rank for Viromed Medical AG's PE Ratio (TTM) or its related term are showing as below:

FRA:VME' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 135   Med: 221.43   Max: 264.29
Current: 242.86


During the past 5 years, the highest PE Ratio (TTM) of Viromed Medical AG was 264.29. The lowest was 135.00. And the median was 221.43.


FRA:VME's PE Ratio (TTM) is ranked worse than
96.55% of 435 companies
in the Medical Devices & Instruments industry
Industry Median: 26.74 vs FRA:VME: 242.86

Viromed Medical AG's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was €0.04. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03.

As of today (2026-07-03), Viromed Medical AG's share price is €6.80. Viromed Medical AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03. Therefore, Viromed Medical AG's PE Ratio without NRI for today is 242.86.

During the past 5 years, Viromed Medical AG's highest PE Ratio without NRI was 264.29. The lowest was 135.00. And the median was 221.43.

Viromed Medical AG's EPS without NRI for the six months ended in Dec. 2025 was €0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03.

Viromed Medical AG's EPS (Basic) for the six months ended in Dec. 2025 was €0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03.


Viromed Medical AG  (FRA:VME) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Viromed Medical AG PE Ratio (TTM) Related Terms


Viromed Medical AG PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG PE Ratio (TTM) Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio (TTM)
N/A N/A N/A At Loss 134.29

Viromed Medical AG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only N/A At Loss At Loss At Loss 134.29

FRA:VME vs ABT, SYK, MDT: PE Ratio (TTM) Comparison

For the Medical Devices subindustry, Viromed Medical AG's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viromed Medical AG PE Ratio (TTM) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Viromed Medical AG's PE Ratio (TTM) falls into.


FRA:VME
22GF Score
Viromed Medical AG FRA:VME
PE Ratio (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viromed Medical AG PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Viromed Medical AG's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=6.80/0.028
=242.86

Viromed Medical AG's Share Price of today is €6.80.
For company reported semi-annually, Viromed Medical AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio (TTM) →
What does a PE Ratio (TTM) of 242.86 mean?
Viromed Medical AG (FRA:VME) has a PE Ratio (TTM) of 242.86 as of Jul. 03, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Viromed Medical AG and its competitors. This is 10% above median its historical median of 221.43. Over the past decade, Viromed Medical AG's PE Ratio (TTM) has ranged from 135.00 to 264.29. According to the industry distribution chart, Viromed Medical AG ranks #420 out of 435 companies in the Medical Devices & Instruments industry, placing it in the top 96.6%.
Is Viromed Medical AG's PE Ratio (TTM) too high?
Viromed Medical AG's current PE Ratio (TTM) of 242.86 is 10% above median its 10-year median of 221.43. Over the past 10 years, this metric has ranged from a low of 135.00 to a high of 264.29. The Medical Devices & Instruments industry median PE Ratio (TTM) is 26.74. Viromed Medical AG's value of 242.86 is 808.2% above this industry median. Based on the distribution chart, Viromed Medical AG ranks #420 out of 435 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's PE Ratio (TTM) compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #420 out of 435 companies for PE Ratio (TTM). This places Viromed Medical AG in the lower half of its industry. The industry median PE Ratio (TTM) is 26.74. Viromed Medical AG's value of 242.86 is 808.2% above this benchmark. Historically, Viromed Medical AG's own PE Ratio (TTM) has ranged from 135.00 to 264.29 over the past decade. While the company's 10-year median is 221.43 vs. the industry median of 26.74, Viromed Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 26.74, based on 435 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current PE Ratio (TTM) of 242.86 is 808.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Viromed Medical AG and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 26.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current PE Ratio (TTM) is 242.86, which is 10% above median its own 10-year median of 221.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (FRA:VME) has a current PE Ratio (TTM) of 242.86. The current PE Ratio (TTM) is 242.86, which is 10% above median its 10-year median of 221.43 and 808.2% above the Medical Devices & Instruments industry median of 26.74. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Viromed Medical AG (FRA:VME), the current PE Ratio (TTM) is 242.86 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Other Exchanges VME:Germany
Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score

Get the complete analysis for FRA:VME

PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.80
Price